{"disease":{"id":"ulcerative-colitis-chronic-moderate","name":"ulcerative colitis chronic moderate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04504383","title":"PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Protagonist Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03565939","title":"Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"ParaTech A/S","has_results":false},{"nct_id":"NCT05791487","title":"Combination of Diet and Oral Budesonide for Ulcerative Colitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Wolfson Medical Center","has_results":false},{"nct_id":"NCT04102852","title":"Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"San Giovanni Addolorata Hospital","has_results":false},{"nct_id":"NCT03917095","title":"The Safety and Efficacy of TET Enema in the Treatment of UC","phase":"NA","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT05912712","title":"Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT04353791","title":"Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Oncostellae S.L","has_results":false},{"nct_id":"NCT03716388","title":"Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Dayanand Medical College and Hospital","has_results":false},{"nct_id":"NCT06420492","title":"Study of Novel Therapeutics for Acute Remedy of Colitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03923478","title":"ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Assembly Biosciences","has_results":false},{"nct_id":"NCT05194007","title":"Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Mohammed Bin Rashid University of Medicine and Health Sciences","has_results":false},{"nct_id":"NCT06311123","title":"Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"University of California, San Diego","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}